Octagon Capital Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.4M Sell
1,273,333
-96,667
-7% -$1.09M 3.16% 15
2025
Q1
$15.8M Hold
1,370,000
3.06% 11
2024
Q4
$11.6M Buy
+1,370,000
New +$11.6M 1.91% 22